ELV Elevance Health Inc.
Healthcare$387.85-1.73%ClosedMarket Cap: $84.23B
As of 2026-05-26
Valuation
P/E (TTM)
12.14
PEG
—
P/B
1.98
P/S
0.43
EV/EBITDA
12.10
DCF Value
$1,134.11
FCF Yield
7.5%
Div Yield
1.7%
Margins & Returns
Gross Margin
23.2%
Operating Margin
3.8%
Net Margin
2.6%
ROE
12.0%
ROA
4.2%
ROIC
7.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $50.18B | 18.1% | $2.66B | $1.76B | $— | $1.72 |
| Q4 null | $49.75B | 23.5% | $581.0M | $547.0M | $— | $1.71 |
| FY null | $199.13B | 25.6% | $8.11B | $5.66B | $— | $6.84 |
| Q3 null | $50.71B | 24.8% | $1.76B | $1.19B | $— | $1.71 |
| Q2 null | $49.78B | 26.3% | $2.63B | $1.74B | $— | $1.71 |
| Q1 null | $48.89B | 27.8% | $3.14B | $2.18B | $— | $1.71 |
| Q4 null | $45.44B | 26.3% | $946.0M | $418.0M | $— | $1.63 |
| FY null | $176.81B | 27.9% | $8.89B | $5.98B | $— | $6.52 |
| Q3 null | $45.15B | 27.0% | $1.71B | $1.02B | $— | $1.63 |
| Q2 null | $43.65B | 30.0% | $3.03B | $2.30B | $— | $1.63 |
| Q1 null | $42.58B | 28.3% | $3.20B | $2.25B | $— | $1.63 |
| Q4 2023 | $42.65B | 26.5% | $1.26B | $856.0M | $3.63 | $1.48 |